Skip to content

Dose Escalation and Dose Expansion Study of BBO-10203 in Subjects with Advanced Solid Tumors

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519445-29-00
Acronym
TBBO10203-101
Enrollment
75
Registered
2025-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors

Interventions

None listed

Sponsors

Theras Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026